Third Rock Ventures IV, L.P., Ten Percent Owner at Dianthus Therapeutics, holds 16.86M shares in Tango Therapeutics (Ticker: TNGX), holds 3.06M shares in Dianthus Therapeutics (Ticker: DNTH), holds 1.42M shares in Revolution Medicines (Ticker: RVMD). Most recently, Third Rock Ventures IV, L.P. Sold ― shares of Tango Therapeutics on Sep 17, 2024 for an estimated value of 709.72K.
What is the percentage of profitable transactions made by Third Rock Ventures IV, L.P.?
The percentage of profitable transactions made by Third Rock Ventures IV, L.P. is 38%.
What is the average return per transaction made by Third Rock Ventures IV, L.P.?
The average return per transaction made by Third Rock Ventures IV, L.P. is -6.20%.
What stocks does Third Rock Ventures IV, L.P. hold?
Third Rock Ventures IV, L.P. holds: DNTH, FULC, RVMD, TNGX stocks.
What was Third Rock Ventures IV, L.P.’s latest transaction?
Third Rock Ventures IV, L.P. latest transaction was an Informative Sell of $709.72K.
What was Third Rock Ventures IV, L.P.'s most profitable transaction?
Third Rock Ventures IV, L.P.’s most profitable transaction was an Informative Buy of FULC stock on July 22, 2019. The return on the trade was 39.20%.
What is Third Rock Ventures IV, L.P.'s role in Dianthus Therapeutics?
Third Rock Ventures IV, L.P.'s role in Dianthus Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.